Flybridge

Flybridge is a Boston and New York-based early-stage venture firm with a generalist thesis spanning consumer, enterprise, and selective frontier technology investing, with a track record that includes some healthcare and digital health exposure. The flybridge.com website and the firm’s public profile reflect an established multi-fund platform with brand-name partners (Jeff Bussgang and others) who have written and spoken extensively about venture investing. For healthcare AI founders, Flybridge is a credible generalist option, particularly for businesses with strong product-led growth, B2B SaaS economics, or consumer technology with healthcare applications. Plausible check sizes run 500K to 3M at seed and Series A, with the firm comfortable leading at the earliest stages. Follow-on capacity exists. Founders building healthcare AI with strong software DNA, founder-product fit, and clear category leadership potential should approach. Founders pitching deep biology, regulated medical devices, or healthcare services should look at specialist firms; Flybridge does not advertise that depth. Entry path is warm introduction through the Boston or New York founder networks, especially through Harvard Business School alumni given Bussgang’s faculty role there, or LinkedIn outreach to partners with a sharp pitch. The firm reads inbound and responds, but the signal-to-noise is heavy. Diligence will be sharp on team, market, and product, with a generalist software lens. Expect Flybridge to push hard on category dynamics and founder edge. Bring evidence that you can build a category-defining business, not just a profitable one; the firm invests for outcomes, not lifestyle businesses.